Even as it has filed for a compulsory licence for Covid-19 drug Baricitinib in India, Natco Pharma has already begun rolling out its generic... ...https://timesofindia.indiatimes.com/city/hyderabad/natco-rolls-out-baricitinib-ahead-of-approval-for-patent-waiver/articleshow/82442841.cms
Posted by Equitymaster Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note. Benchmark... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/vy2yoBQzQsM/tm.asp
Shares of the Hyderabad-based Natco Pharma gained as much as 4.27 per cent to hit an intraday high of Rs 935 after it received emergency use... ...https://www.ndtv.com/business/covid-19-medicine-news-natco-pharma-gains-over-4-on-getting-emergency-use-approval-of-covid-19-medicine-2426985
The group that includes Vaibhav Kakkar of L&L partners and Karan Chandhiok of Chandhiok and Mahajan has roped in former Natco Pharma executive CV... ...https://economictimes.indiatimes.com/news/india/delhi-based-lawyers-team-up-to-crowd-source-money-for-makeshift-covid-hospital/articleshow/82357861.cms
Out of the 101 stocks in the index, 53 advanced while 46 declined and 2 stocks remained unchanged. INSIGHTS Read Stock Insights by ET for a quick... ...https://economictimes.indiatimes.com/markets/stocks/news/stock-market-update-midcap-stocks-advance-natco-pharma-leaps-7/articleshow/81967691.cms
Aromasin 25mg tablets also may be...
Temozolomide is an oral chemotherapy...
Temodar temozolomide 250mg capsules...